Molecular Templates, Inc. Announces $45 Million Debt Financing From K2 HealthVentures May 22, 2020 8:00am EDT
New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II May 15, 2020 7:00am EDT
Molecular Templates, Inc. Announces that the 2020 Annual Meeting of Stockholders Will be Held in Virtual Format May 07, 2020 4:30pm EDT
Molecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple Myeloma Feb 19, 2020 7:00am EST
Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors Dec 19, 2019 7:00am EST
